Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.

导出 OA

翻译打印收藏纠错

作者： Robert T,Greenlee ^[1] ; Alan S,Go ^[2] ; Pamela N,Peterson ^[3] ; Andrea E,Cassidy-Bushrow ^[4] ; Charles,Gaber ^[5] ; Romel,Garcia-Montilla ^[6] ; Karen A,Glenn ^[7] ; Nigel,Gupta ^[8] ; Jerry H,Gurwitz ^[9] ; Stephen C,Hammill ^[10] ; John J,Hayes ^[11] ; Alan,Kadish ^[7] ; David J,Magid ^[12] ; David D,McManus ^[8] ; Deborah,Multerer ^[10] ; J David,Powers ^[7] ; Liza M,Reifler ^[8] ; Kristi,Reynolds ^[8] ; Claudio,Schuger ^[13] ; Param P,Sharma ^[6] ; David H,Smith ^[7] ; Mary,Suits ^[14] ; Sue Hee,Sung ^[7] ; Paul D,Varosy ^[2] ; Humberto J,Vidaillet ^[15] ; Frederick A,Masoudi ^[7]

作者单位： Marshfield Clinic, Marshfield, WI greenlee.robert@marshfieldresearch.org. ^[1] Kaiser Permanente Northern California, Oakland, CA. ^[2] Denver Health Medical Center, Denver, CO. ^[3] University of Colorado Anschutz Medical Campus, Aurora, CO. ^[4] Henry Ford Health System, Detroit, MI. ^[5] University of Michigan, Ann Arbor, MI. ^[6] Marshfield Clinic, Marshfield, WI. ^[7] Kaiser Permanente Colorado, Denver, CO. ^[8] Kaiser Los Angeles Medical Center, Los Angeles, CA. ^[9] University of Massachusetts Medical School, Worcester, MA. ^[10] Mayo Clinic, Rochester, MN. ^[11] Touro College, New York, NY. ^[12] Kaiser Permanente Southern California, Pasadena, CA. ^[13] Kaiser Permanente Northwest, Portland, OR. ^[14] Department of Veterans Affairs Eastern Colorado Health System, Denver, CO. ^[15]

关键词 arrhythmia implantable cardioverter‐defibrillator inappropriate shock outcomes research sudden cardiac death